Literature DB >> 33797958

Computing the Hazard Ratios Associated With Explanatory Variables Using Machine Learning Models of Survival Data.

Sameer Sundrani1,2, James Lu1.   

Abstract

PURPOSE: The application of Cox proportional hazards (CoxPH) models to survival data and the derivation of hazard ratio (HR) are well established. Although nonlinear, tree-based machine learning (ML) models have been developed and applied to the survival analysis, no methodology exists for computing HRs associated with explanatory variables from such models. We describe a novel way to compute HRs from tree-based ML models using the SHapley Additive exPlanation values, which is a locally accurate and consistent methodology to quantify explanatory variables' contribution to predictions.
METHODS: We used three sets of publicly available survival data consisting of patients with colon, breast, or pan cancer and compared the performance of CoxPH with the state-of-the-art ML model, XGBoost. To compute the HR for explanatory variables from the XGBoost model, the SHapley Additive exPlanation values were exponentiated and the ratio of the means over the two subgroups was calculated. The CI was computed via bootstrapping the training data and generating the ML model 1,000 times. Across the three data sets, we systematically compared HRs for all explanatory variables. Open-source libraries in Python and R were used in the analyses.
RESULTS: For the colon and breast cancer data sets, the performance of CoxPH and XGBoost was comparable, and we showed good consistency in the computed HRs. In the pan-cancer data set, we showed agreement in most variables but also an opposite finding in two of the explanatory variables between the CoxPH and XGBoost result. Subsequent Kaplan-Meier plots supported the finding of the XGBoost model.
CONCLUSION: Enabling the derivation of HR from ML models can help to improve the identification of risk factors from complex survival data sets and to enhance the prediction of clinical trial outcomes.

Entities:  

Year:  2021        PMID: 33797958     DOI: 10.1200/CCI.20.00172

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  2 in total

1.  Predicting disease activity in patients with multiple sclerosis: An explainable machine-learning approach in the Mavenclad trials.

Authors:  Sreetama Basu; Alain Munafo; Ali-Frederic Ben-Amor; Sanjeev Roy; Pascal Girard; Nadia Terranova
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05-09

2.  Update to improve reproducibility and interpretability: A response to "Machine Learning for Tumor Growth Inhibition".

Authors:  Phyllis Chan; James Lu; René Bruno; Jin Y Jin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.